A recent study suggests that people who come off new slimming jabs like Mounjaro or Wegovy may regain reduced body mass much more quickly than those who stop conventional diet and exercise programs.
Findings released in a leading health publication shows that while overweight individuals often shed a large proportion of their total mass while undergoing treatment, the mass comes back at an average rate of nearly a kilo each month upon discontinuation.
"Individuals purchasing these drugs need to be cognizant of the danger of quick weight regain when the medication is stopped," warns expert Dr. Susan Jebb.
That rate of recovery means a reversion to starting mass within about one and a half years.
Weighing Treatments
The analysis, which examined 37 of trials involving over 9,000 of patients, contrasted the outcomes of GLP-1 agonists with conventional dieting.
Scientists emphasize that people who lose weight through dieting usually experience a less rapid creep back—perhaps 0.1 kg a month—after stopping.
The Reason for the Quick Regain
Nutrition scientists propose the mechanism of the injections accounts for the heightened regain.
These medications mimic a body's own chemical called GLP-1, which helps regulate feelings of fullness.
"Artificially providing the hormone levels far above than the body's typical production may cause the body to produce less of its endogenous GLP-1, and may also lessen responsiveness to its effects," noted Dr. Adam Collins, a nutrition expert.
"Withdrawal of this medication means hunger is unsuppressed, making overeating far more likely."
A Chronic Issue?
Medical guidelines suggest the jabs for people with weight-linked medical conditions, accompanied by prescribed diet and exercise modifications.
Professionals argue that, considering the high risk of relapse, the therapy might need to be ongoing.
This view is echoed by pharmaceutical companies, who note that the findings "highlight the chronic nature of obesity," similar to managing diseases like high blood pressure.
User Testimonies
Individuals who have come off the medication report a sudden return of appetite.
"It was like a trigger activating and I was suddenly extremely hungry," recalled one woman.
This challenge is exacerbated if users have not established sustainable lifestyle or habit changes during therapy.
Widespread Adoption
Survey data suggest that a significant number of adults in the UK have used these injections in the past year, with desire being substantial.
- Adoption is more common among females than males.
- The 40s and 50s demographic shows the highest usage rates.
- Many access the medications through private healthcare rather than public health services.
Finally, experts stress that while the jabs are potent tools for weight loss, they are not a standalone solution and long-term success hinges on combined lifestyle changes.
